188 related articles for article (PubMed ID: 1730818)
1. Comparative studies of the erythroid-potentiating effects of biosynthetic human insulin-like growth factors-I and -II.
Merchav S; Silvian-Drachsler I; Tatarsky I; Lake M; Skottner A
J Clin Endocrinol Metab; 1992 Feb; 74(2):447-52. PubMed ID: 1730818
[TBL] [Abstract][Full Text] [Related]
2. Human colony-forming units-erythroid do not require accessory cells, but do require direct interaction with insulin-like growth factor I and/or insulin for erythroid development.
Sawada K; Krantz SB; Dessypris EN; Koury ST; Sawyer ST
J Clin Invest; 1989 May; 83(5):1701-9. PubMed ID: 2651478
[TBL] [Abstract][Full Text] [Related]
3. Induction of circulating neonatal stem cell populations.
Dainiak N; Sanders M; Sorba S
Blood Cells; 1991; 17(2):339-43. PubMed ID: 1912598
[TBL] [Abstract][Full Text] [Related]
4. Insulin-like growth factors stimulate erythropoiesis in serum-substituted umbilical cord blood cultures.
Sanders M; Sorba S; Dainiak N
Exp Hematol; 1993 Jan; 21(1):25-30. PubMed ID: 8417957
[TBL] [Abstract][Full Text] [Related]
5. Comparative studies of the granulopoietic enhancing effects of biosynthetic human insulin-like growth factors I and II.
Merchav S; Lake M; Skottner A
J Cell Physiol; 1993 Oct; 157(1):178-83. PubMed ID: 8408236
[TBL] [Abstract][Full Text] [Related]
6. The Raf-1 protein mediates insulin-like growth factor-induced proliferation of erythroid progenitor cells.
Sanders MR; Lu H; Walker F; Sorba S; Dainiak N
Stem Cells; 1998; 16(3):200-7. PubMed ID: 9617895
[TBL] [Abstract][Full Text] [Related]
7. Modulation of erythropoiesis and myelopoiesis by exogenous erythropoietin in human long-term marrow cultures.
Mayani H; Guilbert LJ; Janowska-Wieczorek A
Exp Hematol; 1990 Mar; 18(3):174-9. PubMed ID: 2303109
[TBL] [Abstract][Full Text] [Related]
8. Effects of five recombinant hematopoietic growth factors on enriched human erythroid progenitors in serum-replaced cultures.
Mitjavila MT; Natazawa M; Brignaschi P; Debili N; Breton-Gorius J; Vainchenker W
J Cell Physiol; 1989 Mar; 138(3):617-23. PubMed ID: 2647773
[TBL] [Abstract][Full Text] [Related]
9. Enhancement of human granulopoiesis in vitro by biosynthetic insulin-like growth factor I/somatomedin C and human growth hormone.
Merchav S; Tatarsky I; Hochberg Z
J Clin Invest; 1988 Mar; 81(3):791-7. PubMed ID: 2963830
[TBL] [Abstract][Full Text] [Related]
10. Effect of stem cell factor (c-kit ligand), granulocyte-macrophage colony stimulating factor and interleukin 3 on hematopoietic progenitors in human long-term bone marrow cultures.
Lemoli RM; Gulati SC
Stem Cells; 1993 Sep; 11(5):435-44. PubMed ID: 7694721
[TBL] [Abstract][Full Text] [Related]
11. Enhancement of erythropoiesis in vitro by human growth hormone is mediated by insulin-like growth factor I.
Merchav S; Tatarsky I; Hochberg Z
Br J Haematol; 1988 Nov; 70(3):267-71. PubMed ID: 2849979
[TBL] [Abstract][Full Text] [Related]
12. The role of insulin (INS) and insulin-like growth factor-I (IGF-I) in regulating human erythropoiesis. Studies in vitro under serum-free conditions--comparison to other cytokines and growth factors.
Ratajczak J; Zhang Q; Pertusini E; Wojczyk BS; Wasik MA; Ratajczak MZ
Leukemia; 1998 Mar; 12(3):371-81. PubMed ID: 9529132
[TBL] [Abstract][Full Text] [Related]
13. Effects of recombinant human tumor necrosis factor on highly enriched hematopoietic progenitor cell populations from normal human bone marrow and peripheral blood and bone marrow from patients with chronic myeloid leukemia.
Wisniewski D; Strife A; Atzpodien J; Clarkson BD
Cancer Res; 1987 Sep; 47(18):4788-94. PubMed ID: 3040231
[TBL] [Abstract][Full Text] [Related]
14. Effects of human recombinant erythropoietin on differentiation and distribution of erythroid progenitor cells on murine medullary and splenic erythropoiesis during hypoxia and post-hypoxia.
Mide SM; Huygens P; Bozzini CE; Fernandez Pol JA
In Vivo; 2001; 15(2):125-32. PubMed ID: 11317516
[TBL] [Abstract][Full Text] [Related]
15. Stimulation of human hematopoietic progenitor cell proliferation and differentiation by recombinant human interleukin 3. Comparison and interactions with recombinant human granulocyte-macrophage and granulocyte colony-stimulating factors.
Ottmann OG; Abboud M; Welte K; Souza LM; Pelus LM
Exp Hematol; 1989 Feb; 17(2):191-7. PubMed ID: 2463933
[TBL] [Abstract][Full Text] [Related]
16. Action of antithymocyte globulin on normal human erythroid progenitor cell proliferation in vitro: erythropoietic growth-enhancing factors are released from marrow accessory cells.
Mangan KF; D'Alessandro L; Mullaney MT
J Lab Clin Med; 1986 Apr; 107(4):353-64. PubMed ID: 2420910
[TBL] [Abstract][Full Text] [Related]
17. Dependence of highly enriched human bone marrow progenitors on hemopoietic growth factors and their response to recombinant erythropoietin.
Sieff CA; Emerson SG; Mufson A; Gesner TG; Nathan DG
J Clin Invest; 1986 Jan; 77(1):74-81. PubMed ID: 3511093
[TBL] [Abstract][Full Text] [Related]
18. Effect of recombinant human interleukin 3, granulocyte-macrophage colony-stimulating factor and granulocyte colony-stimulating factor on human BFU-e in serum-free cultures.
Misago M; Chiba S; Kikuchi M; Tsukada J; Sato T; Oda S; Eto S
Int J Cell Cloning; 1989 Jan; 7(1):39-49. PubMed ID: 2465360
[TBL] [Abstract][Full Text] [Related]
19. Stem cell factor (c-kit ligand) enhances the interleukin-9-dependent proliferation of human CD34+ and CD34+CD33-DR- cells.
Lemoli RM; Fortuna A; Fogli M; Motta MR; Rizzi S; Benini C; Tura S
Exp Hematol; 1994 Aug; 22(9):919-23. PubMed ID: 7520394
[TBL] [Abstract][Full Text] [Related]
20. Interleukin-11 stimulates the proliferation of human hematopoietic CD34+ and CD34+CD33-DR- cells and synergizes with stem cell factor, interleukin-3, and granulocyte-macrophage colony-stimulating factor.
Lemoli RM; Fogli M; Fortuna A; Motta MR; Rizzi S; Benini C; Tura S
Exp Hematol; 1993 Dec; 21(13):1668-72. PubMed ID: 7694867
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
